Genetic Studies of Early-onset Dementia
Columbia University · with University of Miami, National Institute on Aging (NIA) · NCT04906863
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 35+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 1000
- US sites recruiting
- 1
- Study start
- September 14, 2016
- Record last updated
- April 29, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The aim of this study is to identify genetic factors that contribute to risk and progression of early-onset dementia (loss of memory function before the age of 70 years) across all ethnic groups, including Alzheimer's Disease, mild cognitive impairment and other dementias.
Being studied: Blood draw; Neurocognitive testing; Medical questionnaire
Conditions: Dementia, Early Onset; Alzheimer Dementia (AD); Mild Cognitive Impairment (MCI); Memory Loss
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion criteria
- 35 years and older
- Individuals experiencing memory concerns or diagnosed with dementia and their family members that are unrelated healthy controls without dementia.
Exclusion Criteria
- Individuals with competing diagnosis such as Huntington's disease, traumatic brain injury, drug or alcohol abuse, or schizophrenia, etc., unless family members of a dementia affected individual
Recruiting US locations
Columbia University Irving Medical Center
New York, NY 10032
Site contact: Pamela del Rosario, MD · 212-304-7284 · pd2727@cumc.columbia.edu
Study contacts (from the official record)
- Pamela Del Rosario · 212-304-7284 · pd2727@cumc.columbia.edu
Similar studies in New York
All neurology studies in New York →- RecruitingHealthy volunteersPhase 1
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics And Pharmacodynamics of SIF001 in Healthy Subjects and in Epilepsy Patients
Suninflam Inc
- Location
- Amherst, NY + 9 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingHealthy volunteersEarly Phase 1
Chronic Transcutaneous Stimulation to Promote Motor Function and Recovery in Individuals With Paralysis or Paresis
Northwell Health
- Location
- Manhasset, NY
- Eligibility basics
- Ages 18–75
- RecruitingHealthy volunteersPhase 1
Repetitive Transcranial Magnetic Stimulation for Post-concussion Headaches
State University of New York - Upstate Medical University
- Location
- Syracuse, NY
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteers
MyVitalC: Sleep and Everyday Headache Management
Efforia, Inc
- Location
- New York, NY
- Eligibility basics
- Any age listed